SurgiVision's MRI-compatible cannula wins FDA clearance
20 April 2011
SurgiVision, Inc has receieved FDA aproval for its SmartFlow
neuro ventricular cannula, an MRI-compatible injection and aspiration
cannula for use in the brain. It is compatible with SurgiVision’s
ClearPoint system.
Using the new SmartFlow cannula with the ClearPoint system,
neurosurgeons can select a neurological target, navigate the
SmartFlow cannula to the target and observe the delivery of the
therapeutic agent, all under intra-procedural MRI guidance. Other
features of the SmartFlow cannula include a multi-step tip design to
help prevent reflux along the cannula shaft.
“The medical community is continuing to find therapeutic agents
that hold great promise in treating various CNS disorders, however
many of these agents will require precision delivery, direct into a
small neuro target,” said Kimble Jenkins, CEO of SurgiVision. “It is
our hope that SurgiVision’s expanding range of products in
interventional MRI could help fill this need and lead to better
therapies for patients.”